Stock Events

Stock Events

Bio Green Med Solution 

€0.000000
93
+€0.00+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
May 25
€0.13
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

12AugExpected
Q1 2026
Next
-0.03
0.3
0.63
0.97
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow UXI1.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap160.36B
Gilead Sciences is a biopharmaceutical company that competes in the development of drugs in areas such as oncology, where Cyclacel also operates.
AMGEN
AMGN
Mkt Cap188.67B
Amgen is a biotech firm focusing on human therapeutics, including treatments for cancer, which puts it in direct competition with Cyclacel's oncology focus.
Bristol-Myers Squibb
BMY
Mkt Cap116.95B
Bristol-Myers Squibb is involved in discovering, developing, and delivering innovative medicines, including cancer treatments that compete with Cyclacel's product pipeline.
Pfizer
PFE
Mkt Cap148.41B
Pfizer is a global pharmaceutical corporation with a broad portfolio, including oncology, directly competing with Cyclacel's cancer-focused therapies.
Merck
MRK
Mkt Cap298.33B
Merck is known for its high-quality research and development in pharmaceuticals, including cancer drugs, making it a competitor to Cyclacel.
Novartis
NVS
Mkt Cap284.61B
Novartis is a healthcare company that focuses on innovative medicines, with a strong emphasis on oncology, competing with Cyclacel in the cancer treatment market.
Abbvie
ABBV
Mkt Cap401.47B
AbbVie operates in the discovery of new medicines, including for cancer, directly competing with Cyclacel's research and development in oncology.
Astrazeneca
AZN
Mkt Cap288.38B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in oncology, competing with Cyclacel.
Roche
RHHBY
Mkt Cap331.58B
Roche Holding AG is a pioneer in healthcare, with a strong focus on pharmaceuticals and diagnostics in oncology, making it a competitor to Cyclacel.
Johnson & Johnson
JNJ
Mkt Cap560.33B
Johnson & Johnson is a diverse healthcare company that has a pharmaceutical segment involved in the development of oncology treatments, competing with Cyclacel.

About

A diversified company operating in both the fire protection and biopharmaceutical industries. It expanded its portfolio by acquiring Fitters Sdn. Bhd., a Malaysian fire protection products and services group. Focuses on advancing opportunities in biopharmaceutical research and fire safety solutions to create sustainable long-term shareholder value.
Show more...
CEO
Dr. Sing Ee Wong
Employees
12
Country
United States
ISIN
US23254L8761

Listings

XNAS
US
BGMS
MU
DE
UXI1.MU
STU
DE
UXI1.STU
OTC Link
US
BGMSP

0 Comments

Share your thoughts

FAQ

What is Bio Green Med Solution stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bio Green Med Solution stocks are traded under the ticker UXI1.MU.
When is the next Bio Green Med Solution earnings date?▼
Bio Green Med Solution is going to release the next earnings report on August 12, 2026.
What were Bio Green Med Solution earnings last quarter?▼
UXI1.MU earnings for the last quarter are -0.03 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Bio Green Med Solution pay dividends?▼
Yes, UXI1.MU dividends are paid annual. The last dividend per share was 0.13 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Bio Green Med Solution have?▼
As of June 11, 2026, the company has 12 employees.
In which sector is Bio Green Med Solution located?▼
Bio Green Med Solution operates in the Health & Wellness sector.
When did Bio Green Med Solution complete a stock split?▼
Bio Green Med Solution has not had any recent stock splits.
Where is Bio Green Med Solution headquartered?▼
Bio Green Med Solution is headquartered in Kuala Lumpur, United States.